Inhibition of rat liver ribonucleic acid polymerase by the carcinogen N-hydroxy-2-fluorenylacetamide.
D000081:Acetamides / Q000494:pharmacology; D000818:Animals; D002247:Carbon Isotopes; D002467:Cell Nucleus / Q000201:enzymology / Q000378:metabolism; D005260:Female; D005449:Fluorenes / Q000494:pharmacology*; D006877:Hydroxamic Acids / Q000494:pharmacology; D006900:Hydroxylation; D007700:Kinetics; D008099:Liver / Q000166:cytology / Q000187:drug effects / Q000201:enzymology*; D008274:Magnesium / Q000494:pharmacology; D008297:Male; D009963:Orotic Acid / Q000378:metabolism; D012313:RNA / Q000096:biosynthesis; D012316:RNA Nucleotidyltransferases / Q000037:antagonists & inhibitors* / Q000378:metabolism; D051381:Rats; D011919:Rats, Inbred Strains; D013698:Templates, Genetic; D013997:Time Factors; D014500:Uracil Nucleotides / Q000378:metabolism
D000081:Acetamides; D002247:Carbon Isotopes; D005449:Fluorenes; D006877:Hydroxamic Acids; D014500:Uracil Nucleotides; D009963:Orotic Acid; D012313:RNA; D012316:RNA Nucleotidyltransferases; D008274:Magnesium